Abstract
Drugs modulate disease states through their actions on targets in the body. Determining these targets aids the focused development of new treatments, and helps to better characterize those already employed. One means of accomplishing this is through the deployment of in silico methodologies, harnessing computational analytical and predictive power to produce educated hypotheses for experimental verification. Here, we provide an overview of the current state of the art, describe some of the well-established methods in detail, and reflect on how they, and emerging technologies promoting the incorporation of complex and heterogeneous data-sets, can be employed to improve our understanding of (poly)pharmacology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Berman HM (2000) The protein data bank. Nucleic Acids Res 28:235–242
Piovesan D, Luigi Martelli P, Fariselli P et al (2011) BAR-PLUS: the bologna annotation resource plus for functional and structural annotation of protein sequences. Nucleic Acids Res 39:197–202
Villoutreix BO, Lagorce D, Labbé CM et al (2013) One hundred thousand mouse clicks down the road: Selected online resources supporting drug discovery collected over a decade. Drug Discov Today 18:1081–1089
Kamburov A, Wierling C, Lehrach H, Herwig R (2009) ConsensusPathDB–a database for integrating human functional interaction networks. Nucleic Acids Res 37:623–628
Ogata H, Goto S, Sato K et al (1999) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34
Tym JE, Mitsopoulos C, Coker EA et al (2016) canSAR: An updated cancer research and drug discovery knowledgebase. Nucleic Acids Res 44:938–943
Chen X, Ji ZL, Chen YZ (2002) TTD: therapeutic target database. Nucleic Acids Res 30:412–415
Loging W, Rodriguez-Esteban R, Hill J et al (2011) Cheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing. Drug Discov Today Ther Strateg 8:109–116
Bickle M (2010) The beautiful cell: High-content screening in drug discovery. Anal Bioanal Chem 398:219–226
Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353–359
Chaudhari R, Tan Z, Zhang S (2017) Overview of drug polypharmacology and multitargeted molecular design. In: Davis A, Edge C (eds) In silico drug discovery tools, Comprehensive medicinal chemistry III, vol 2. Elsevier, Amsterdam, pp 259–275
Hu Y, Bajorath J (2013) Compound promiscuity: What can we learn from current data? Drug Discov Today 18:644–650
Frantz S (2005) Drug discovery: playing dirty. Nature 437:942–943
Mencher SK, Wang LG (2005) Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol 5:3
Keiser MJ, Irwin JJ, Shoichet BK (2010) The chemical basis of pharmacology. Biochemistry 49:10267–10276
Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
Russ AP, Lampel S (2005) The druggable genome: An update. Drug Discov Today 10:1607–1610
Bunnage ME (2011) Getting pharmaceutical R&D back on target. Nat Chem Biol 7:335–339
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
Wishart DS (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:668–672
Santos R, Ursu O, Gaulton A et al (2016) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19–34
Von Eichborn J, Murgueitio MS, Dunkel M et al (2011) PROMISCUOUS: A database for network-based drug-repositioning. Nucleic Acids Res 39:1060–1066
Yildirim MA, Goh K-I, Cusick ME et al (2007) Drug-target network. Nat Biotechnol 25:1119–1126
Jalencas X, Mestres J (2013) On the origins of drug polypharmacology. Med Chem Commun 4:80–87
Lounkine E, Keiser MJ, Whitebread S et al (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature 486:361–367
Imming P, Sinning C, Meyer A (2006) Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov 5:821–834
Bunnage ME, Gilbert AM, Jones LH, Hett EC (2015) Know your target, know your molecule. Nat Chem Biol 11:368–372
Jordan AM, Waddell ID, Ogilvie DJ (2015) Rethinking “academic” drug discovery: The Manchester Institute perspective. Drug Discov Today 20:525–535
Rask-Andersen M, Almén MS, Schiöth HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10:579–590
Duan Q, Reid SP, Clark NR et al (2016) L1000CDS2: LINCS L1000 characteristic direction signatures search engine. NPJ Syst Biol Appl 2:1–12
Humbeck L, Koch O (2017) What can we learn from bioactivity data? Chemoinformatics tools and applications in chemical biology research. ACS Chem Biol 12:23–35
Koutsoukas A, Simms B, Kirchmair J et al (2011) From in silico target prediction to multi-target drug design: Current databases, methods and applications. J Proteome 74:2554–2574
Jenkins JL, Bender A, Davies JW (2006) In silico target fishing: Predicting biological targets from chemical structure. Drug Discov Today Technol 3:413–421
Peón A, Dang CC, Ballester PJ (2016) How reliable are ligand-centric methods for target fishing? Front Chem 4:15
Nettles JH, Jenkins JL, Bender A et al (2006) Bridging chemical and biological space: “Target fishing” using 2D and 3D molecular descriptors. J Med Chem 49:6802–6810
Lavecchia A, Cerchia C (2015) In silico methods to address polypharmacology: Current status, applications and future perspectives. Drug Discov Today 21:288–298
Menziani MC, Montorsi M, De Benedetti PG, Karelson M (1999) Relevance of theoretical molecular descriptors in quantitative structure-activity relationship analysis of alpha1-adrenergic receptor antagonists. Bioorg Med Chem 7:2437–2451
Verma J, Khedkar V, Coutinho E (2010) 3D-QSAR in drug design–a review. Curr Top Med Chem 10:95–115
Brogi S, Papazafiri P, Roussis V, Tafi A (2013) 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors. Eur J Med Chem 67:344–351
Wermuth CG, Ganellin CR, Lindberg P, Mitscher LA (1998) IUPAC recommendations: glossary of terms used in medicinal chemistry. Pure Appl Chem 70:1129–1143
Gfeller D, Michielin O, Zoete V (2013) Shaping the interaction landscape of bioactive molecules. Bioinformatics 29:3073–3079
Schuffenhauer A, Floersheim P, Acklin P, Jacoby E (2003) Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci 43:391–405
Bender A, Jenkins JL, Scheiber J et al (2009) How similar are similarity searching methods? A principal component analysis of molecular descriptor space. J Chem Inf Model 49:108–119
Willett P (2000) Chemoinformatics–similarity and diversity in chemical libraries. Curr Opin Biotechnol 11:85–88
Pahikkala T, Airola A, Pietilä S et al (2015) Toward more realistic drug-target interaction predictions. Brief Bioinform 16:325–337
Daylight Information Systems (2008) Daylight theory: fingerprints. Accessed 8 Jul 2017
Bajusz D, Rácz A, Héberger K (2015) Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminform 7:1–13
Baldi P, Nasr R (2010) When is chemical similarity significant? The statistical distribution of chemical similarity scores and its extreme values. J Chem Inf Model 50:1205–1222
Arif SM, Holliday JD, Willett P (2009) Analysis and use of fragment-occurrence data in similarity-based virtual screening. J Comput Aided Mol Des 23:655–668
Arif SM, Holliday JD, Willett P (2016) The use of weighted 2D fingerprints in similarity-based virtual screening. Adv Math Chem Appl Revis Ed 1:92–112
Willett P, Barnard JM, Downs GM (1998) Chemical similarity searching. J Chem Inf Comput Sci 38:983–996
Keiser MJ, Roth BL, Armbruster BN et al (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25:197–206
Kruskal JB (1956) On the shortest spanning subtree of a graph and the traveling salesman problem. Proc Am Math Soc 7:48–48
Bento AP, Gaulton A, Hersey A et al (2014) The ChEMBL bioactivity database: An update. Nucleic Acids Res 42:D1083–D1090
Olah M, Mracec M, Ostopovici L et al (2005) WOMBAT: world of molecular bioactivity. In: Oprea TI (ed) Chemoinformatics in drug discovery. Wiley-VCH Verlag GmbH & Co. KGaA, Weinham, pp 221–239
Symyx MDL Technologies, Dassault Systèmes BIOVIA (2009) MDL drug data report. Accessed 6 Jul 2017
Inpharmatica Ltd. (2005) StARLITe. Accessed 8 Aug 2017
Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res 42:32–38
Armstrong MS, Finn PW, Morris GM, Richards WG (2011) Improving the accuracy of ultrafast ligand-based screening: Incorporating lipophilicity into ElectroShape as an extra dimension. J Comput Aided Mol Des 25:785–790
Kramer C, Kalliokoski T, Gedeck P, Vulpetti A (2012) The experimental uncertainty of heterogeneous public K i data. J Med Chem 55:5165–5173
Reker D, Rodrigues T, Schneider P, Schneider G (2014) Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Natl Acad Sci U S A 111:4067–4072
Schneider N, Giller S (1999) Scaffold-hopping by topological pharmacophore search: A contribution to virtual screening. Angew Chem Int Ed Engl 38:2894–2896
Reutlinger M, Koch CP, Reker D et al (2013) Chemically advanced template search (CATS) for scaffold-hopping and prospective target prediction for “orphan” molecules. Mol Inf 32:133–138
Molecular Operating Environment (MOE), Chemical Computing Group, Montreal, Canada, 2011
Kohonen T (1982) Self-organized formation of topologically correct feature maps. Biol Cybern 43:59–69
Schneider P, Tanrikulu Y, Schneider G (2009) Self-organising maps in drug discovery: Compound library design, scaffold-hopping, repurposing. Curr Med Chem 16:258–266
Schneider G, Tanrikulu Y, Schneider P (2009) Self-organizing molecular fingerprints: A ligand-based view on drug-like chemical space and off-target prediction. Future Med Chem 1:213–218
Schneider P, Schneider G (2003) Collection of bioactive reference compounds for focused library design. QSAR Comb Sci 22:713–718
Nickel J, Gohlke BO, Erehman J et al (2014) SuperPred: Update on drug classification and target prediction. Nucleic Acids Res 42:W26–W31
Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50:742–754
Günther S, Kuhn M, Dunkel M et al (2008) SuperTarget and matador: resources for exploring drug-target relationships. Nucleic Acids Res 36:919–922
Chen X, Liu M, Gilson MK (2001) BindingDB: a web-accessible molecular recognition database. Comb Chem High Throughput Screen 4:719–725
Gilson MK, Liu T, Baitaluk M et al (2016) BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:D1045–D1053
Awale M, Reymond JL (2017) The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data. J Cheminform 9:1
Liu X, Vogt I, Haque T, Campillos M (2013) HitPick: A web server for hit identification and target prediction of chemical screenings. Bioinformatics 29:1910–1912
Mussa HY, Mitchell JBO, Glen RC (2013) Full “laplacianised” posterior naive Bayesian algorithm. J Cheminform 5:37
Kuhn M, Szklarczyk D, Franceschini A et al (2012) STITCH 3: Zooming in on protein-chemical interactions. Nucleic Acids Res 40:D876–D880
Szklarczyk D, Santos A, Von Mering C et al (2016) STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44:D380–D384
Lagunin A, Stepanchikova A, Filimonov D, Poroikov V (2000) PASS: Prediction of activity spectra for biologically active substances. Bioinformatics 16:747–748
Poroikov VV, Filimonov DA, Ihlenfeldt WD et al (2003) PASS biological activity spectrum predictions in the enhanced open NCI Database Browser. J Chem Inf Comput Sci 43:228–236
Filimonov DA, Poroikov VV (1996) PASS: Computerized prediction of biological activity spectra for chemical substances. In: Bioactive compound design: possibilities for industrial use. BIOS Scientific Publishers, Oxford, pp 47–56
Filimonov D, Poroikov V, Borodina Y, Gloriozova T (1999) Chemical similarity assessment through multilevel neighborhoods of atoms: Definition and comparison with the other descriptors. J Chem Inf Comput Sci 39:666–670
Wang Z, Liang L, Yin Z, Lin J (2016) Improving chemical similarity ensemble approach in target prediction. J Cheminform 8:20
Weibull W (1951) A statistical distribution function of wide applicability. J Appl Mech 18:293–297
Nadarajah S (2003) Extreme value theory, models and simulation. In: Shanbhag D, Rao C (eds) Stochastic processes: modelling and simulation, Handbook of Statistics, vol 21. Elsevier, Amsterdam, pp 607–691
Altschul SF, Gish W, Miller W et al (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Schneider P, Stutz K, Kasper L et al (2011) Target profile prediction and practical evaluation of a biginelli-type dihydropyrimidine compound library. Pharmaceuticals 4(9):1236–1247
Morgan HL (1965) The generation of a unique machine description for chemical structures–A technique developed at chemical abstracts service. J Chem Doc 5:107–113
Avidon VV, Pomerantsev IA, Golender VE, Rozenblit AB (1982) Structure-activity relationship oriented languages for chemical structure representation. J Chem Inf Comput Sci 22:207–214
Nigsch F, Bender A, Jenkins JL, Mitchell JBO (2008) Ligand-target prediction using winnow and naive bayesian algorithms and the implications of overall performance statistics. J Chem Inf Model 48:2313–2325
Nidhi, Glick M, Davies JW, Jenkins JL (2006) Prediction of biological targets for compounds using multiple-category bayesian models trained on chemogenomics databases. J Chem Inf Model 46:1124–1133
Drakakis G, Koutsoukas A, Brewerton S et al (2015) Comparing global and local likelihood score thresholds in multiclass Laplacian-modified naive Bayes protein target prediction. Comb Chem High Throughput Screen 18:323–330
Koutsoukas A, Lowe R, Kalantarmotamedi Y et al (2013) In silico target predictions: Defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt Window. J Chem Inf Model 53:1957–1966
Nobeli I, Favia AD, Thornton JM (2009) Protein promiscuity and its implications for biotechnology. Nat Biotechnol 27:157–167
Blencowe BJ (2006) Alternative splicing: New insights from global analyses. Cell 126:37–47
Pan Q, Shai O, Lee LJ et al (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413–1415
McCarthy JJ, Hilfiker R (2000) The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 18:505–508
Roden DM, George AL Jr (2002) The genetic basis of variability in drug responses. Nat Rev Drug Discov 1:37–44
Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683–691
Prabakaran S, Lippens G, Steen H, Gunawardena J (2012) Post-translational modification: Nature’s escape from genetic imprisonment and the basis for dynamic information encoding. Wiley Interdiscip Rev Syst Biol Med 4:565–583
Bedford L, Lowe J, Dick LR et al (2011) Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 10:29–46
Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG (2007) Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 6:541–555
Vogel C, Bashton M, Kerrison ND et al (2004) Structure, function and evolution of multidomain proteins. Curr Opin Struct Biol 14:208–216
Bashton M, Chothia C (2007) The generation of new protein functions by the combination of domains. Structure 15:85–99
Song N, Joseph JM, Davis GB, Durand D (2008) Sequence similarity network reveals common ancestry of multidomain proteins. PLoS Comput Biol 4:e1000063
Day R, Beck DAC, Armen RS (2003) A consensus view of fold space: Combining SCOP, CATH, and the Dali Domain Dictionary. Protein Sci 12:2150–2160
Cuff AL, Sillitoe I, Lewis T et al (2011) Extending CATH: increasing coverage of the protein structure universe and linking structure with function. Nucleic Acids Res 39:D420–D426
Hammes GG, Chang Y-C, Oas TG (2009) Conformational selection or induced fit: A flux description of reaction mechanism. Proc Natl Acad Sci U S A 106:13737–13741
Csermely P, Palotai R, Nussinov R (2010) Induced fit, conformational selection and independent dynamic segments: An extended view of binding events. Trends Biochem Sci 35:539–546
Fischer E (1894) Einfluss der Konfiguration auf die Wirkung der Enzyme. Berichte der Dtsch Chem Gesellschaft 27:2985–2993
Koshland DE (1960) The active site and enzyme action. Adv Enzymol Relat Areas Mol Biol 22:45–97
Koshland DE (1958) Application of a theory of enzyme specificity to protein synthesis. Proc Natl Acad Sci U S A 44:98–104
Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: A plausible model. J Mol Biol 12:88–118
Motlagh HN, Wrabl JO, Li J, Hilser VJ (2014) The ensemble nature of allostery. Nature 508:331–339
Vega S, Abian O, Velazquez-Campoy A (2016) On the link between conformational changes, ligand binding and heat capacity. Biochim Biophys Acta 1860:868–878
Shanmugasundaram V, Zhang L, Kayastha S et al (2016) Monitoring the progression of structure-activity relationship information during lead optimization. J Med Chem 59:4235–4244
Grünberg R, Leckner J, Nilges M (2004) Complementarity of structure ensembles in protein-protein binding. Structure 12:2125–2136
Vogt AD, Di Cera E (2013) Conformational selection is a dominant mechanism of ligand binding. Biochemistry 52:5723–5729
Vogt AD, Di Cera E (2012) Conformational selection or induced fit? A critical appraisal of the kinetic mechanism. Biochemistry 51:5894–5902
Changeux JP, Edelstein S (2011) Conformational selection or induced-fit? 50 years of debate resolved. F1000 Biol Rep 3:19
Lange OF, Lakomek NA, Farès C et al (2008) Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science 320:1471–1475
Kar G, Keskin O, Gursoy A, Nussinov R (2010) Allostery and population shift in drug discovery. Curr Opin Pharmacol 10:715–722
Michel D (2016) Conformational selection or induced fit? New insights from old principles. Biochimie 128–129:48–54
Galburt EA, Tomko EJ (2017) Conformational selection and induced fit as a useful framework for molecular motor mechanisms. Biophys Chem 223:11–16
Ekroos M, Sjogren T (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci U S A 103:13682–13687
De Vivo M, Masetti M, Bottegoni G, Cavalli A (2016) Role of molecular dynamics and related methods in drug discovery. J Med Chem 59:4035–4061
Feixas F, Lindert S, Sinko W, McCammon JA (2014) Exploring the role of receptor flexibility in structure-based drug discovery. Biophys Chem 186:31–45
Buonfiglio R, Recanatini M, Masetti M (2015) Protein flexibility in drug discovery: From theory to computation. ChemMedChem 10:1141–1148
Teague SJ (2003) Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2:527–541
Lahti JL, Tang GW, Capriotti E et al (2012) Bioinformatics and variability in drug response: a protein structural perspective. J R Soc Interface 9:1409–1437
Xie L, Xie L, Bourne PE (2009) A unified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery. Bioinformatics 25:305–312
Kahraman A, Morris RJ, Laskowski RA, Thornton JM (2007) Shape variation in protein bindign pockets and their ligands. J Mol Biol 368:283–301
Kellenberger E, Schalon C, Rognan D (2008) How to measure the similarity between protein-ligand binding sites? Curr Comput Aided Drug Des 4:209–220
Pérot S, Sperandio O, Miteva MA et al (2010) Druggable pockets and binding site centric chemical space: A paradigm shift in drug discovery. Drug Discov Today 15:656–667
Schmitt S, Kuhn D, Klebe G (2002) A new method to detect related function among proteins independent of sequence and fold homology. J Mol Biol 323:387–406
Bron C, Kerbosch J (1973) Algorithm 457: Finding all cliques of an undirected graph. Commun ACM 16:575–577
Jambon M, Imberty A, Deléage G, Geourjon C (2003) A new bioinformatic approach to detect common 3D sites in protein structures. Proteins 52:137–145
Jambon M, Andrieu O, Combet C et al (2005) The SuMo server: 3D search for protein functional sites. Bioinformatics 21:3929–3930
Chartier M, Najmanovich R (2015) Detection of binding site molecular interaction field similarities. J Chem Inf Model 55:1600–1615
Chartier M, Adriansen E, Najmanovich R (2015) IsoMIF Finder: Online detection of binding site molecular interaction field similarities. Bioinformatics 32:621–623
Yeturu K, Chandra N (2008) PocketMatch: a new algorithm to compare binding sites in protein structures. BMC Bioinformatics 9:543
Hoffmann B, Zaslavskiy M, Vert J-P, Stoven V (2010) A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand prediction. BMC Bioinformatics 11:99
Wang X, Pan C, Gong J et al (2016) Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs. J Chem Inf Model 56:1175–1183
Liu X, Ouyang S, Yu B et al (2010) PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res 38:W609–W614
Wang X, Shen Y, Wang S et al (2017) PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45(W1):W356–W360.
Altschul SF, Madden TL, Schäffer AA et al (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389–3402
Yuan Y, Pei J, Lai L (2013) Binding site detection and druggability prediction of protein targets for structure-based drug design. Curr Pharm Des 19:2326–2333
Chen J, Ma X, Yuan Y et al (2014) Protein-protein interface analysis and hot spots identification for chemical ligand design. Curr Pharm Des 20:1192–1200
Warren GL, Andrews CW, Capelli A-M et al (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912–5931
Bourne PE, Beran B, Bi C et al (2011) The evolution of the RCSB protein data bank website. Wiley Interdiscip Rev Comput Mol Sci 1:782–789
Zardecki C, Dutta S, Goodsell DS et al (2016) RCSB protein data bank: A resource for chemical, biochemical, and structural explorations of large and small biomolecules. J Chem Educ 93:569–575
Ellingson SR, Smith JC, Baudry J (2013) VinaMPI: Facilitating multiple receptor high-throughput virtual docking on high-performance computers. J Comput Chem 34:2212–2221
Chen HM, Liu BF, Huang HL et al (2007) SODOCK: Swarm optimization for highly flexible protein-ligand docking. J Comput Chem 28:612–623
Liu Y, Zhao L, Li W et al (2013) FIPSDock: A new molecular docking technique driven by fully informed swarm optimization algorithm. J Comput Chem 34:67–75
Chen YZ, Zhi DG (2001) Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins Struct Funct Genet 43:217–226
Li H, Gao Z, Kang L et al (2006) TarFisDock: A web server for identifying drug targets with docking approach. Nucleic Acids Res 34:W219–W224
Gao Z, Li H, Zhang H et al (2008) PDTD: A web-accessible protein database for drug target identification. BMC Bioinformatics 9:104
Lang PT, Brozell SR, Mukherjee S et al (2009) DOCK 6: Combining techniques to model RNA-small molecule complexes. RNA 15:1219–1230
Wang JC, Chu PY, Chen CM, Lin JH (2012) idTarget: A web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach. Nucleic Acids Res 40:W393–W399
Chang DTH, Oyang YJ, Lin JH (2005) MEDock: A web server for efficient prediction of ligand binding sites based on a novel optimization algorithm. Nucleic Acids Res 33:W233–W238
Kellenberger E, Muller P, Schalon C et al (2006) sc-PDB: An annotated database of druggable binding sites from the Protein Data Bank. J Chem Inf Model 46:717–727
Luo H, Chen J, Shi L et al (2011) DRAR-CPI: A server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res 39:W492–W498
Smith RD, Hu L, Falkner JA et al (2006) Exploring protein-ligand recognition with Binding MOAD. J Mol Graph Model 24:414–425
Pronk S, Páll S, Schulz R et al (2013) GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854
Phillips JC, Braun R, Wang W et al (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781–1802
Wassenaar TA, van Dijk M, Loureiro-Ferreira N et al (2012) WeNMR: Structural biology on the grid. J Grid Comput 10:743–767
Van Dijk M, Wassenaar TA, Bonvin AMJJ (2012) A flexible, grid-enabled web portal for GROMACS molecular dynamics simulations. J Chem Theory Comput 8:3463–3472
Hospital A, Andrio P, Fenollosa C et al (2012) MDWeb and MDMoby: An integrated web-based platform for molecular dynamics simulations. Bioinformatics 28:1278–1279
Chen Z, Rappert S, Sun J, Zeng AP (2011) Integrating molecular dynamics and co-evolutionary analysis for reliable target prediction and deregulation of the allosteric inhibition of aspartokinase for amino acid production. J Biotechnol 154:248–254
Páll S, Abraham MJ, Kutzner C et al (2015) Tackling exascale software challenges in molecular dynamics simulations with GROMACS. In: Markidis S, Laure E (eds) Lecture notes in computer science, vol 8759. Springer, Cham, pp 3–27
Bowers KJ, Sacerdoti FD, Salmon JK et al (2006) Molecular dynamics–Scalable algorithms for molecular dynamics simulations on commodity clusters. In: SC ‘06: Proceedings of the 2006 ACM/IEEE conference on supercomputing. ACM New York, Tampa, pp 84–96
Mestres J, Gregori-Puigjané E, Valverde S, Solé RV (2009) The topology of drug–target interaction networks: implicit dependence on drug properties and target families. Mol BioSyst 5:1051
Luo Q, Pagel P, Vilne B, Frishman D (2011) DIMA 3.0: Domain interaction map. Nucleic Acids Res 39:D724–D729
Weisel M, Kriegl JM, Schneider G (2010) Architectural repertoire of ligand-binding pockets on protein surfaces. ChemBioChem 11:556–563
Prud’hommeaux E, Seaborne A (2008) SPARQL query language for RDF. W3C Recomm 2009:1–106
Harris S, Seaborne A (2014) SPARQL 1.1 query language. W3C Recomm 2009:1–106
Chen B, Ding Y, Wild DJ (2012) Assessing drug target association using semantic linked data. PLoS Comput Biol 8:e1002574
Ashburner M, Ball CA, Blake JA et al (2000) Gene ontology: Tool for the unification of biology. Nat Genet 25:25–29
Blake JA, Christie KR, Dolan ME et al (2015) Gene ontology consortium: Going forward. Nucleic Acids Res 43:D1049–D1056
Degtyarenko K, De Matos P, Ennis M et al (2008) ChEBI: A database and ontology for chemical entities of biological interest. Nucleic Acids Res 36:D344–D350
de Matos P, Alcántara R, Dekker A et al (2009) Chemical entities of biological interest: An update. Nucleic Acids Res 38:D249–D254
Law V, Knox C, Djoumbou Y et al (2014) DrugBank 4.0: Shedding new light on drug metabolism. Nucleic Acids Res 42:D1091–D1097
Chen B, Dong X, Jiao D et al (2010) Chem2Bio2RDF: A semantic framework for linking and data mining chemogenomic and systems chemical biology data. BMC Bioinformatics 11:255
Chen B, Ding Y, Wild DJ (2012) Improving integrative searching of systems chemical biology data using semantic annotation. J Cheminform 4:6
Dijkstra EW (1959) A note on two problems in connexion with graphs. Numer Math 1:269–271
Kong X, Cao B, Yu PS (2013) Multi-label classification by mining label and instance correlations from heterogeneous information networks categories and subject descriptors. In: Dhillon I et al (eds) Proceedings of the 19th ACM SIGKDD International conference on knowledge discovery and data mining. ACM Press, New York, pp 614–622
Wang W, Yang S, Zhang X, Li J (2014) Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 30:2923–2930
Fakhraei S, Huang B, Raschid L, Getoor L (2014) Network-based drug-target interaction prediction with probabilistic soft-logic. In: IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol 11. IEEE Computer society press, Los Alamitos, pp 775–787
Klipp E, Wade RC, Kummer U (2010) Biochemical network-based drug-target prediction. Curr Opin Biotechnol 21:511–516
Campillos M, Kuhn M, Gavin A-C et al (2008) Drug target identification using side-effect similarity. Science 321:263–266
Yamanishi Y, Kotera M, Kanehisa M, Goto S (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26:i246–i254
Takarabe M, Kotera M, Nishimura Y et al (2012) Drug target prediction using adverse event report systems: A pharmacogenomic approach. Bioinformatics 28:i611–i618
Yamanishi Y, Kotera M, Moriya Y et al (2014) DINIES: Drug-target interaction network inference engine based on supervised analysis. Nucleic Acids Res 42:W39–W45
Zhang X, Li L, Ng MK, Zhang S (2017) Drug-target interaction prediction by integrating multiview network data. Comput Biol Chem 69:185–190
Kanehisa M, Goto S, Furumichi M et al (2009) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38:D355–D360
Pawson AJ, Sharman JL, Benson HE et al (2014) The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res 42:D1098–D1106
Hagberg AA, Schult DA, Swart PJ (2008) Exploring network structure, dynamics, and function using NetworkX. In: Varoquax G et al. (eds) SciPy 2008: Proceedings of the 7th python in science conference, Pasadena, 2008
Van Der Walt S, Colbert SC, Varoquaux G (2011) The NumPy array: A structure for efficient numerical computation. Comput Sci Eng 13:22–30
Tosco P, Stiefl N, Landrum G (2014) Bringing the MMFF force field to the RDKit: Implementation and validation. J Cheminform 6:37
Landrum G (2016) The RDKit Documentation–The RDKit 2016.09.1 documentation. Accessed 18 Aug 2017
Python Software Foundation (2017) The Python Language Reference–Python 2.7.13 documentation. Accessed 18 Aug 2017
Bastian M, Heymann S, Jacomy M et al (2009) Gephi: an open source software for exploring and manipulating networks. In: Third international AAAI conference on weblogs and social media, San Jose, 17–20 May 2009
Jacomy M, Venturini T, Heymann S, Bastian M (2014) ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software. PLoS One 9:e98679
Boutet E, Lieberherr D, Tognolli M et al (2007) UniProtKB/Swiss-Prot. Methods Mol Biol 406:89–112
Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887–2893
Franceschini A, Szklarczyk D, Frankild S et al (2013) STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41:808–815
Forbes SA, Beare D, Gunasekaran P et al (2015) COSMIC: Exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res 43:D805–D811
Flicek P, Amode MR, Barrell D et al (2014) Ensembl 2014. Nucleic Acids Res 42:D749–D755
Lundstrom K (2006) The ultimate approach for rational drug design. Struct Genomics 34:205–212
Kaldor SW, Kalish VJ, Davies JF et al (1997) Viracept (nelfinavir mesylate, AG1343): A potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem 40:3979–3985
Xie L, Bourne PE (2007) A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites. BMC Bioinformatics 8:S9
Xie L, Evangelidis T, Xie L, Bourne PE (2011) Drug discovery using chemical systems biology: Weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput Biol 7:e1002037
Csermely P, Korcsmáros T, Kiss HJM et al (2013) Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review. Pharmacol Ther 138:333–408
Mei H, Xia T, Feng G et al (2012) Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases. Drug Discov Today 17:1208–1216
Kell DB, Goodacre R (2014) Metabolomics and systems pharmacology: Why and how to model the human metabolic network for drug discovery. Drug Discov Today 19:171–182
Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259
Chautard E, Thierry-Mieg N, Ricard-Blum S (2009) Interaction networks: From protein functions to drug discovery. A review. Pathol Biol 57:324–333
Raj A, Rifkin SA, Andersen E, van Oudenaarden A (2010) Variability in gene expression underlies incomplete penetrance. Nature 463:913–918
Susaki EA, Ukai H, Ueda HR (2017) Next-generation mammalian genetics toward organism-level systems biology. Syst Biol Appl 3:15
Jerby L, Ruppin E (2012) Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin Cancer Res 18:5572–5584
Folger O, Jerby L, Frezza C et al (2014) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7:501
Azuaje FJ, Zhang L, Devaux Y, Wagner DR (2011) Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs. Sci Rep 1:52
Chelliah V, Juty N, Ajmera I et al (2015) BioModels: Ten-year anniversary. Nucleic Acids Res 43:D542–D548
Raman K, Chandra N (2009) Flux balance analysis of biological systems: Applications and challenges. Brief Bioinform 10:435–449
Fang X, Wallqvist A, Reifman J (2009) A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis. BMC Syst Biol 3:92
Martinez V, Navarro C, Cano C et al (2015) DrugNet: Network-based drug-disease prioritization by integrating heterogeneous data. Artif Intell Med 63:41–49
Zhang Y, Thiele I, Weekes D et al (2009) Three-dimensional structural view of the central metabolic network of Thermotoga maritima. Science 325:1544–1549
Kessler RM, Ansari MS, de Paulis T et al (1991) High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med 32:1593–1600
Hopkins AL, Mason JS, Overington JP (2006) Can we rationally design promiscuous drugs? Curr Opin Struct Biol 16:127–136
Denessiouk KA, Johnson MS (2000) When fold is not important: A common structural framework for adenine and AMP binding in 12 unrelated protein families. Proteins Struct Funct Genet 38:310–326
Lalande L, Bourguignon L, Maire P, Goutelle S (2016) Mathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study. J Theor Biol 399:43–52
Raman K, Chandra N (2008) Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance. BMC Microbiol 8:234.
Rokem JS, Lantz AE, Nielsen J (2007) Systems biology of antibiotic production by microorganisms. Nat Prod Rep 24:1262–1287
Kinnings SL, Xie L, Fung KH et al (2010) The Mycobacterium tuberculosis drugome and its polypharmacological implications. PLoS Comput Biol 6:e1000976
Wist AD, Berger SI, Iyengar R (2009) Systems pharmacology and genome medicine: a future perspective. Genome Med 1:11
Jin G, Zhao H, Zhou X, Wong STC (2011) An enhanced Petri-Net model to predict synergistic effects of pairwise drug combinations from gene microarray data. Bioinformatics 27:310–316
Winter GE, Rix U, Carlson SM et al (2012) Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. Nat Chem Biol 8:905–912
Jin G, Fu C, Zhao H et al (2012) A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res 72:33–44
Ryall KA, Tan AC (2015) Systems biology approaches for advancing the discovery of effective drug combinations. J Cheminform 7:7
Li P, Chen J, Wang J et al (2014) Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases. J Ethnopharmacol 151:93–107
Kell DB (2015) The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on their bulk biophysical properties: Towards a systems pharmacology. Perspect Sci 6:66–83
Mitchell JBO (2014) Machine learning methods in chemoinformatics. Wiley Interdiscip Rev Comput Mol Sci 4:468–481
Azencott CA, Ksikes A, Swamidass SJ et al (2007) One- to four-dimensional kernels for virtual screening and the prediction of physical, chemical, and biological properties. J Chem Inf Model 47:965–974
Nascimento ACA, Prudêncio RBC, Costa IG (2016) A multiple kernel learning algorithm for drug-target interaction prediction. BMC Bioinformatics 17:46
Lima AN, Philot EA, Trossini GHG et al (2016) Use of machine learning approaches for novel drug discovery. Expert Opin Drug Discov 11:225–239
Ekins S, de Siqueira-Neto JL, McCall L-I et al (2015) Machine learning models and pathway genome data base for Trypanosoma cruzi drug discovery. PLoS Negl Trop Dis 9:e0003878
Williams K, Bilsland E, Sparkes A et al (2015) Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases. J R Soc Interface 12:1289
Gasteiger J (2003) Physicochemical effects in the representation of molecular structures for drug designing. Mini Rev Med Chem 3:789–796
Sawada R, Kotera M, Yamanishi Y (2014) Benchmarking a wide range of chemical descriptors for drug-target interaction prediction using a chemogenomic approach. Mol Inf 33:719–731
Hinton GE, Salakhutdinov RR (2006) Reducing the dimensionality of data with neural networks. Science 313:504–507
LeCun Y, Yoshua B, Geoffrey H (2015) Deep learning. Nature 521:436–444
Gawehn E, Hiss JA, Schneider G (2016) Deep learning in drug discovery. Mol Inf 35:3–14
Unterthiner T, Ceulemans H, Steijaert M (2014) Multi-task deep networks for drug target prediction. In: Ghahramani Z et al (eds) NIPS 2014: Proceedings of the neural information processing systems foundation meeting, Montréal, 2014
Lusci A, Pollastri G, Baldi P (2013) Deep architectures and deep learning in chemoinformatics: The prediction of aqueous solubility for drug-like molecules. J Chem Inf Model 53:1563–1575
Faber FA, Hutchison L, Huang B, et al (2017) Fast machine learning models of electronic and energetic properties consistently reach approximation errors better than DFT accuracy. arXiv:1702.05532
Ma J, Sheridan RP, Liaw A et al (2015) Deep neural nets as a method for quantitative structure-activity relationships. J Chem Inf Model 55:263–274
Goh GB, Siegel C, Vishnu A et al (2017) Chemception: A deep neural network with minimal chemistry knowledge matches the performance of expert-developed QSAR/QSPR models. arXiv:1706.06689
Mayr A, Klambauer G, Unterthiner T, Hochreiter S (2016) DeepTox: Toxicity prediction using deep learning. Front Environ Sci 3:80
Ramsundar B, Liu B, Zhenqin W et al (2017) Is multitask deep learning practical for pharma? J Chem Inf Model.
Wang Q, Feng Y, Huang J et al (2017) A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine. PLoS One 12:e0176486
Unterthiner T, Mayr A, Klambauer G et al (2014) In: Ghahramani Z et al (eds) NIPS 2014: Proceedings of the neural information processing systems foundation meeting, Montréal, 2014
Ralaivola L, Swamidass SJ, Saigo H, Baldi P (2005) Graph kernels for chemical informatics. Neural Netw 18:1093–1110
Azencott CA, Borgwardt K (2014) Data mining in bioinformatics–Graph mining in chemoinformatics. Accessed 6 Jul 2017
Gilmer J, Schoenholz SS, Riley PF et al (2017) Neural message passing for quantum chemistry. arXiv:1704.01212
Defferrard M, Bresson X, Vandergheynst P (2016) Convolutional neural networks on graphs with fast localized spectral filtering. Adv Neural Inform Process Syst 29:3844–3852
Niepert M, Ahmed M, Kutzkov K (2016) Learning convolutional neural networks for graphs. J Mach Learn Res 48:2014–2023
Altae-Tran H, Ramsundar B, Pappu AS, Pande V (2017) Low data drug discovery with one-shot learning. ACS Cent Sci 3:283–293
Merck & Co., Inc (2012) Merck molecular activity challenge, Accessed 4 Aug 2017
Chen B, Sheridan RP, Hornak V, Voigt JH (2012) Comparison of random forest and Pipeline Pilot naïve Bayes in prospective QSAR predictions. J Chem Inf Model 52:792–803
Dahl GE, Jaitly N, Salakhutdinov R (2015) Deep neural nets as a method for quantitative structure-activity relationships. J Chem Inf Model 55:263–274
Dahl GE, Jaitly N (2012) Post discussing authors’ methodology and success in Merck Kaggle competition. Accessed 4 Aug 2017
Markoff J (2012) New York Times coverage of the Merck competition. Accessed 4 Aug 2017
Kearnes S, McCloskey K, Berndl M et al (2016) Molecular graph convolutions: moving beyond fingerprints. J Comput Aided Mol Des 30:595–608
Scarselli F, Gori M, Tsoi AC et al (2009) The graph neural network model. IEEE Trans Neural Netw 20:61–80
Szegedy C, Liu W, Jia Y et al (2015) Going deeper with convolutions. In: Conference on computer vision and pattern recognition (CVPR), Boston, MA, 7–12 Jun 2015
Karpathy A, Li FF (2015) Deep visual-semantic alignments for generating image descriptions. IEEE Trans Pattern Anal Mach Intell 39:664–676
Silla CN, Freitas AA (2011) A survey of hierarchical classification across different application domains. Data Min Knowl Discov 22:31–72
Ragoza M, Hochuli J, Idrobo E et al (2017) Protein-ligand scoring with convolutional neural networks. J Chem Inf Model 57:942–957
Wang Y, Zeng J (2013) Predicting drug-target interactions using restricted Boltzmann machines. Bioinformatics 29:i126–i134
Laggner C, Kokel D, Setola V et al (2012) Chemical informatics and target identification in a zebrafish phenotypic screen. Nat Chem Biol 8:144–146
Liggi S, Drakakis G, Koutsoukas A et al (2014) Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts. Future Med Chem 6:2029–2056
Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4:649–663
Klenner A, Hartenfeller M, Schneider P, Schneider G (2010) “Fuzziness” in pharmacophore-based virtual screening and de novo design. Drug Discov Today Technol 7:e237–e244
Hartenfeller M, Schneider G (2011) Enabling future drug discovery by de novo design. Wiley Interdiscip Rev Comput Mol Sci 1:742–759
Schneider P, Schneider G (2016) De novo design at the edge of chaos. J Med Chem 59:4077–4086
Koes DR, Camacho CJ (2011) Pharmer: Efficient and exact pharmacophore search. J Chem Inf Model 51:1307–1314
Koes DR, Camacho CJ (2012) ZINCPharmer: Pharmacophore search of the ZINC database. Nucleic Acids Res 40:W409–W414
Acknowledgment
This research was supported by the European Union Framework Programme for Research and Innovation (Horizon 2020, Marie Skłodowska-Curie ITN grant number 675555 ‘AEGIS’), and the OPO-Foundation Zurich.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Byrne, R., Schneider, G. (2019). In Silico Target Prediction for Small Molecules. In: Ziegler, S., Waldmann, H. (eds) Systems Chemical Biology. Methods in Molecular Biology, vol 1888. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8891-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8891-4_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8890-7
Online ISBN: 978-1-4939-8891-4
eBook Packages: Springer Protocols